An anti-inflammatory drug colchicine may have additional potential to treat cardiovascular diseases, a study published yesterday suggests. The study and editorial focused on the use of colchicine in cardiovascular diseases have been published in the renowned journal Heart. Many studies to date have suggested that inflammation is a significant factor in the pathogenesis of cardiovascular diseases. Since inflammation seems to be an important factor, treating it may seem important key in minimizing cardiovascular disease risk.
The new meta-analysis and Cochrane- the review has highlighted the potential use of colchicine as an anti-inflammatory agent in the prevention of cardiovascular diseases. The study is published yesterday on April 9, 2016, in the renowned international journal Heart. The journal has published several studies and reviews about colchicine and its potential in treating…
